RECRO PHARMA INC (REPH) Stock Balance Sheet
NASDAQ:REPH
Current stock price
2.09
-0.01 (-0.48%)
At close:
2.09
0 (0%)
After Hours:
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 25.22M | 23.80M | 19.10M | 38.50M | 61.00M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 3.50M | |||
| Receivables | 20.48M | 16.40M | 23.20M | 18.10M | 9.70M | |||
| Inventories | 8.92M | 11.60M | 15.10M | 10.70M | 9.80M | |||
| Other Current Assets | 2.92M | 2.30M | 2.70M | 3.90M | 3.30M | |||
| Total Current Assets | 57.53M | 54.10M | 60.20M | 71.10M | 87.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 57.63M | 44.30M | 42.70M | 45.60M | 39.10M | |||
| Intangibles | 3.83M | 700.00K | 3.30M | 32.30M | 34.90M | |||
| Other Non-Current Assets | 246.00K | N/A | N/A | 0.00 | 18.60M | |||
| Total Non-Current Assets | 102.79M | 49.30M | 50.30M | 84.40M | 98.90M | |||
| TOTAL ASSETS | 160.32M | 103.40M | 110.50M | 155.50M | 186.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.04M | 1.50M | N/A | N/A | 0.00 | |||
| Accrued Expenses | 11.30M | 3.10M | 4.00M | 14.10M | 9.40M | |||
| Accounts Payable | 2.08M | 1.80M | 1.00M | 4.50M | 8.00M | |||
| Other Current Liabilities | 2.31M | 1.40M | 1.50M | 10.40M | 32.60M | |||
| Total Current Liabilities | 17.73M | 7.80M | 6.50M | 29.00M | 49.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 95.50M | 108.10M | 110.30M | 64.20M | 53.60M | |||
| Other Non-Current Liabilities | 5.02M | 1.60M | 400.00K | 81.70M | 53.90M | |||
| Total Non-Current Liabilities | 100.52M | 109.70M | 110.70M | 146.00M | 107.50M | |||
| TOTAL LIABILITIES | 118.25M | 117.50M | 117.20M | 175.00M | 157.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -245.75M | -234.40M | -206.90M | -188.30M | -111.30M | |||
| Additional Paid In Capital | 287.35M | 220.00M | 199.90M | 168.50M | 140.00M | |||
| Common Shares | 467.00K | 300.00K | 200.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 46.68M | 28.60M | 23.30M | 21.80M | 19.10M | |||
| Tangible Book Value per Share | -0.06 | -0.67 | -0.61 | -2.67 | -0.65 | |||
| Total Shareholders' Equity | 42.06M | -14.10M | -6.70M | -19.50M | 28.80M | |||
| TOTAL LIABILITIES AND EQUITY | 160.32M | 103.40M | 110.50M | 155.50M | 186.20M | |||
| Statistics | ||||||||
| Debt/Equity | 2.27 | -7.67 | -16.46 | -3.29 | 1.86 | |||
| Current Ratio | 3.24 | 6.94 | 9.26 | 2.45 | 1.75 | |||
| Return On Assets (ROA) | -7.09% | -26.60% | -16.86% | -51.27% | -26.90% | |||
| Return On Equity (ROE) | -27.03% | N/A | N/A | N/A | -173.89% | |||
| Return On Invested Capital (ROIC) | 0.23% | N/A | 17.95% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 0.28% | N/A | 21.99% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 0.29% | N/A | 22.88% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21